Charles River-CRL Stock Up on Q4 Earnings and Revenue Beat, Margins Fall

Charles River Laboratories International, Inc. (CRL) reported fourth-quarter 2024 adjusted earnings per share (EPS) of $2.66, which rose 8.1% year over year. The figure surpassed the Zacks Consensus Estimate by 6.4%.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.On a GAAP basis, the company reported a loss of$ 4.22 per share against the year-ago quarter’s earnings of $3.62 per share. The company reported full-year 2024 EPS of$ 10.32, which decreased 3.3% from the prior-year level. ...